Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Vaping hub (19)
- Compliance and enforcement (18)
- Advertising (16)
- Legislation (15)
- Safety monitoring and information (12)
- Manufacturing (11)
- COVID-19 (8)
- Import and export (8)
- Labelling and packaging (8)
- Medicinal cannabis hub (6)
- Scheduling (national classification system) (5)
- Weight loss products (3)
- Clinical trials (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Shortages and supply disruptions (1)
- Sunscreens (1)
Search
119 result(s) found, displaying 101 to 119
-
Media releasesWe have updated our guidance on advertising cosmetic injectables to ensure advertising rules are applied consistently across all industries that deal with therapeutic goods.
-
Regulatory decision noticesFind out how listed medicine ingredients, and requirements for their use, have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
-
Regulatory decision noticesFrom 3 June 2024, we will be using a new Good Manufacturing Practice (GMP) guide for medicines, active pharmaceutical ingredients and sunscreens.
-
Regulatory decision noticesThe TGA and Health Canada have signed a Memorandum of Understanding to further increase collaboration and reliance on Good Manufacturing Practice inspections conducted in countries outside each other's borders.
-
Media releasesTherapeutic goods and records have been seized from a pharmacy in Melbourne. This is part of our investigation into the alleged unlawful manufacture, supply and export of therapeutic goods.
-
Media releasesThe targeted consultation is part of a proposal to change the Therapeutic Goods Regulations 1990 to mitigate safety risks in the compounding of GLP-1 RAs.
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Regulatory decision noticesAnnouncement about the launch of the pilot Single Inspection Program, a global approach to Good Manufacturing Practice inspections of third country manufacturers.
-
Media releasesThe TGA has issued 13 infringement notices totalling $42,900 to a New South Wales-based individual for the alleged unlawful advertisement and supply of erectile dysfunction medicines.
-
Media releasesThe Australian Border Force (ABF) and partners have seized more than five and a half million cigarette sticks and prevented hundreds of thousands of prohibited vapes and drug items from reaching the streets of Sydney.
-
Regulatory decision noticesThis instrument is made under regulation 97 of the Therapeutic Goods Regulations 1990.
-
Regulatory decision noticesThis instrument is made under Schedule 5A to the Therapeutic Goods Regulations 1990 and Schedule 4 to the Therapeutic Goods (Medical Devices) Regulations 2002.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
Media releasesThe TGA has issued 18 infringement notices totalling $157,752 to Kilpatrick & Douglas Pty Ltd and two directors, for the alleged unlawful advertising of nicotine vapes
-
News articlesOn 1 January 2024, as part of the reforms to the regulation of vaping products, the Advertising Permission for Nicotine was repealed.
-
Media releasesThe TGA with the assistance of NSW Police have seized 478 sport supplements containing potentially dangerous substances from a Sydney retail store.
-
Media releasesWe issued an infringement notice for $13,320 to the New South Wales based company Marvel Health (Australia) Pty Ltd. This was for an alleged failure to comply with a notice to provide information about a complementary (listed) medicine.